1. Home
  2. EMBC vs NAGE Comparison

EMBC vs NAGE Comparison

Compare EMBC & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • NAGE
  • Stock Information
  • Founded
  • EMBC 1924
  • NAGE 1999
  • Country
  • EMBC United States
  • NAGE United States
  • Employees
  • EMBC N/A
  • NAGE N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • NAGE Medicinal Chemicals and Botanical Products
  • Sector
  • EMBC Health Care
  • NAGE Health Care
  • Exchange
  • EMBC Nasdaq
  • NAGE Nasdaq
  • Market Cap
  • EMBC 726.8M
  • NAGE 861.0M
  • IPO Year
  • EMBC N/A
  • NAGE N/A
  • Fundamental
  • Price
  • EMBC $9.96
  • NAGE $9.04
  • Analyst Decision
  • EMBC Buy
  • NAGE Strong Buy
  • Analyst Count
  • EMBC 2
  • NAGE 3
  • Target Price
  • EMBC $19.00
  • NAGE $16.67
  • AVG Volume (30 Days)
  • EMBC 526.4K
  • NAGE 1.2M
  • Earning Date
  • EMBC 08-08-2025
  • NAGE 08-06-2025
  • Dividend Yield
  • EMBC 5.91%
  • NAGE N/A
  • EPS Growth
  • EMBC N/A
  • NAGE N/A
  • EPS
  • EMBC 0.89
  • NAGE 0.18
  • Revenue
  • EMBC $1,079,500,000.00
  • NAGE $107,925,000.00
  • Revenue This Year
  • EMBC N/A
  • NAGE $26.44
  • Revenue Next Year
  • EMBC N/A
  • NAGE $20.06
  • P/E Ratio
  • EMBC $11.39
  • NAGE $50.51
  • Revenue Growth
  • EMBC N/A
  • NAGE 29.77
  • 52 Week Low
  • EMBC $9.20
  • NAGE $2.53
  • 52 Week High
  • EMBC $21.48
  • NAGE $14.69
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 43.81
  • NAGE N/A
  • Support Level
  • EMBC $9.68
  • NAGE N/A
  • Resistance Level
  • EMBC $11.79
  • NAGE N/A
  • Average True Range (ATR)
  • EMBC 0.51
  • NAGE 0.00
  • MACD
  • EMBC -0.05
  • NAGE 0.00
  • Stochastic Oscillator
  • EMBC 22.12
  • NAGE 0.00

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: